Charles Schwab Investment Management Inc. increased its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 47.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,052,384 shares of the company's stock after purchasing an additional 336,807 shares during the quarter. Charles Schwab Investment Management Inc. owned about 2.12% of Nu Skin Enterprises worth $7,640,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of NUS. Prescott Group Capital Management L.L.C. grew its stake in shares of Nu Skin Enterprises by 142.7% during the first quarter. Prescott Group Capital Management L.L.C. now owns 1,394,608 shares of the company's stock valued at $10,125,000 after purchasing an additional 819,972 shares during the last quarter. Pacer Advisors Inc. bought a new stake in shares of Nu Skin Enterprises during the first quarter valued at approximately $4,577,000. Susquehanna International Group LLP grew its stake in shares of Nu Skin Enterprises by 191.9% during the fourth quarter. Susquehanna International Group LLP now owns 702,127 shares of the company's stock valued at $4,838,000 after purchasing an additional 461,608 shares during the last quarter. Two Sigma Advisers LP boosted its stake in Nu Skin Enterprises by 61.2% in the fourth quarter. Two Sigma Advisers LP now owns 944,000 shares of the company's stock valued at $6,504,000 after acquiring an additional 358,400 shares during the last quarter. Finally, D. E. Shaw & Co. Inc. boosted its stake in Nu Skin Enterprises by 15.5% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 2,251,352 shares of the company's stock valued at $15,512,000 after acquiring an additional 301,295 shares during the last quarter. 82.84% of the stock is owned by institutional investors.
Nu Skin Enterprises Stock Up 1.9%
Shares of NYSE:NUS traded up $0.22 during midday trading on Monday, reaching $12.16. 485,119 shares of the company were exchanged, compared to its average volume of 676,633. Nu Skin Enterprises, Inc. has a fifty-two week low of $5.32 and a fifty-two week high of $12.40. The company has a quick ratio of 1.38, a current ratio of 2.01 and a debt-to-equity ratio of 0.27. The stock has a fifty day simple moving average of $9.62 and a two-hundred day simple moving average of $8.04. The firm has a market cap of $602.07 million, a PE ratio of 6.05 and a beta of 0.92.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.18. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. The firm had revenue of $386.14 million for the quarter, compared to analyst estimates of $376.68 million. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. As a group, sell-side analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.
Nu Skin Enterprises Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 10th. Shareholders of record on Friday, August 29th will be paid a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 2.0%. The ex-dividend date is Friday, August 29th. Nu Skin Enterprises's payout ratio is presently 11.94%.
Insider Transactions at Nu Skin Enterprises
In other Nu Skin Enterprises news, Director Daniel W. Campbell sold 23,391 shares of Nu Skin Enterprises stock in a transaction on Friday, August 29th. The shares were sold at an average price of $12.10, for a total value of $283,031.10. Following the sale, the director directly owned 53,375 shares in the company, valued at approximately $645,837.50. The trade was a 30.47% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.00% of the company's stock.
Analyst Ratings Changes
A number of equities analysts have issued reports on NUS shares. Wall Street Zen raised shares of Nu Skin Enterprises from a "buy" rating to a "strong-buy" rating in a research note on Friday, August 22nd. Zacks Research raised shares of Nu Skin Enterprises to a "hold" rating in a research note on Tuesday, August 12th. Three research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $6.88.
View Our Latest Research Report on NUS
Nu Skin Enterprises Profile
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Further Reading

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.